Literature DB >> 18392833

The importance of histology and cytogenetics in decision making for renal cell carcinoma.

Julia G Garcia1, Maria M Picken, Robert C Flanigan.   

Abstract

The role of histology and cytogenetics in the diagnosis of renal cell carcinoma continues to evolve. The symbiotic relationship between histology and cytogenetics helps assure the most accurate diagnosis. Prognostic factors are known and continue to be undiscovered. Patient counseling certainly benefits from this information. Further knowledge and differentiation of renal cell carcinoma disease pathways has allowed for the development of targeted therapies. The benefit of these therapies hinges on the critical diagnosis attained via the role of histology and cytogenetics.

Entities:  

Mesh:

Year:  2008        PMID: 18392833     DOI: 10.1007/s00345-008-0262-3

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  71 in total

Review 1.  Allogeneic hematopoetic stem cell transplantation for cytokine refractory renal cell carcinoma.

Authors:  Darrel Drachenberg; Richard W Childs
Journal:  Cancer Treat Res       Date:  2003

Review 2.  Gastrointestinal stromal tumor: involvement in urologic patients and recent therapeutic advances.

Authors:  Bryan B Voelzke; Kyoko Sakamoto; Alexander Hantel; Gladell P Paner; Joseph Kash; W Bedford Waters; Steven C Campbell
Journal:  Urology       Date:  2002-08       Impact factor: 2.649

3.  Cancer statistics, 1999.

Authors:  S H Landis; T Murray; S Bolden; P A Wingo
Journal:  CA Cancer J Clin       Date:  1999 Jan-Feb       Impact factor: 508.702

4.  Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c-Met-dependent human tumors.

Authors:  Teresa Burgess; Angela Coxon; Susanne Meyer; Jan Sun; Karen Rex; Trace Tsuruda; Qing Chen; Shu-Yin Ho; Luke Li; Stephen Kaufman; Kevin McDorman; Russell C Cattley; Jilin Sun; Gary Elliott; Ke Zhang; Xiao Feng; Xiao-Chi Jia; Larry Green; Robert Radinsky; Richard Kendall
Journal:  Cancer Res       Date:  2006-02-01       Impact factor: 12.701

Review 5.  Targeted anti-cancer therapies for renal cancer.

Authors:  Robert J Amato; Jaroslaw Jac
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 6.  Prognostic factors in renal cancer.

Authors:  J B Thrasher; D F Paulson
Journal:  Urol Clin North Am       Date:  1993-05       Impact factor: 2.241

Review 7.  The role of lymphadenectomy in the surgical management of renal cell carcinoma.

Authors:  Courtney K Phillips; Samir S Taneja
Journal:  Urol Oncol       Date:  2004 May-Jun       Impact factor: 3.498

8.  A novel small molecule met inhibitor induces apoptosis in cells transformed by the oncogenic TPR-MET tyrosine kinase.

Authors:  Martin Sattler; Yuri B Pride; Patrick Ma; Jessica L Gramlich; Stephanie C Chu; Laura A Quinnan; Sheri Shirazian; Congxin Liang; Klaus Podar; James G Christensen; Ravi Salgia
Journal:  Cancer Res       Date:  2003-09-01       Impact factor: 12.701

9.  Renal cell carcinoma with retroperitoneal lymph nodes. Impact on survival and benefits of immunotherapy.

Authors:  Allan J Pantuck; Amnon Zisman; Frederich Dorey; Debby H Chao; Ken-Ryu Han; Jonathan Said; Barbara Gitlitz; Arie S Belldegrun; Robert A Figlin
Journal:  Cancer       Date:  2003-06-15       Impact factor: 6.860

10.  Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma.

Authors:  Stephen D W Beck; Manish I Patel; Mark E Snyder; Michael W Kattan; Robert J Motzer; Victor E Reuter; Paul Russo
Journal:  Ann Surg Oncol       Date:  2004-01       Impact factor: 5.344

View more
  2 in total

1.  Integrated Analysis of Three Publicly Available Gene Expression Profiles Identified Genes and Pathways Associated with Clear Cell Renal Cell Carcinoma.

Authors:  YuPing Han; LinLin Wang; Ye Wang
Journal:  Med Sci Monit       Date:  2020-07-26

2.  Phenotypical screening on metastatic PRCC-TFE3 fusion translocation renal cell carcinoma organoids reveals potential therapeutic agents.

Authors:  Chuanzhen Cao; Xiaomei Lan; Bingqing Shang; Weixing Jiang; Lei Guo; Shan Zheng; Xingang Bi; Aiping Zhou; Zhijian Sun; Jianzhong Shou
Journal:  Clin Transl Oncol       Date:  2022-02-03       Impact factor: 3.340

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.